Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands.

van der Boor, Saskia C; Schmitz-de Vries, Else T J; Smits, Dennis; Scholl, Joep H G; Rolfes, Leàn; van Hunsel, Florence

van der Boor, Saskia C; Schmitz-de Vries, Else T J; Smits, Dennis; Scholl, Joep H G; Rolfes, Leàn; van Hunsel, Florence.

Afiliación

van der Boor SC; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands. Electronic address: saskiavanderboor@gmail.com.
Schmitz-de Vries ETJ; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands. Electronic address: e.schmitz@lareb.nl.
Smits D; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands. Electronic address: d.smits@lareb.nl.
Scholl JHG; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands. Electronic address: j.scholl@lareb.nl.
Rolfes L; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands. Electronic address: l.rolfes@lareb.nl.
van Hunsel F; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands. Electronic address: f.vanhunsel@lareb.nl.

Vaccine ; 41(29): 4319-4326, 2023 06 29.

Article en En | MEDLINE | ID: mdl-37286408

Asunto(s)

Vacunas contra la COVID-19; COVID-19; Humanos; Vacunas contra la COVID-19/efectos adversos; Sistemas de Registro de Reacción Adversa a Medicamentos; Países Bajos/epidemiología; Inmunización Secundaria/efectos adversos; COVID-19/prevención & control; Vacunación/efectos adversos

Palabras clave

Adverse events following immunization; Booster vaccine; COVID-19 basic series; COVID-19 vaccine; Post-marketing monitoring; Spontaneous reporting

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google